PAR Insider Sale: CFO Menar Exercises Options, Sells 6,500 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
PAR Technology Corp. insider transactions by CFO Bryan A. Menar on 09/10/2025
Bryan Menar, Chief Financial Officer, executed a scheduled set of transactions under a Rule 10b5-1 plan on September 10, 2025. He exercised 6,500 employee stock options at an $8.82 exercise price and simultaneously sold 6,500 shares at a weighted-average price of $46.06, reducing his direct common stock holdings from 77,981 to 71,481 shares. The sale prices ranged from $45.31 to $47.56. The underlying option is part of a larger grant exercisable in installments and expires December 8, 2027.
Positive
- Transaction executed under a Rule 10b5-1 trading plan, which provides an affirmative defense and suggests pre-planned liquidity rather than opportunistic trading.
- Clear disclosure of exercise and sale prices, including weighted-average sale price range ($45.31–$47.56), supporting transparency.
Negative
- Reduction in direct ownership from 77,981 to 71,481 shares, representing decreased insider stake.
- Large realized gain (exercise at $8.82 vs sale at $46.06 weighted average) may attract investor attention regarding insider liquidity.
Insights
TL;DR: CFO exercised options and sold the same number of shares under a pre-established 10b5-1 plan, realizing substantial per-share gains.
The filing shows a routine, pre-planned liquidity event rather than an ad hoc insider sale. Exercising options at $8.82 and selling at a weighted average of $46.06 implies a material per-share spread, crystallizing gains for the reporting person. Because the sale was conducted pursuant to a 10b5-1 plan adopted March 10, 2025, the transactions carry the affirmative-defense structure against insider trading allegations, reducing legal/regulatory risk. Ownership decreased modestly but the filing does not indicate any change in executive role or company fundamentals.
TL;DR: Transaction appears procedurally compliant and nonmaterial to control, but it does reduce the officer's direct stake.
The disclosure includes required explanatory footnotes and attorney-in-fact signature, indicating compliance with Form 4 mechanics. The transaction reduced direct holdings by 6,500 shares, a modest change relative to total reported holdings. The existence of a multi-installment option grant and use of a 10b5-1 plan align with common governance practices for planned insider liquidity. No indications of abnormal timing or unusual derivative activity are present in this filing.